Morven K. Shuttleworth
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Upper-Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE Study.
Journal: American journal of respiratory and critical care medicine
Published: September 12, 2025
Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE study.
Journal: Thorax
Published: March 13, 2025
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.
Journal: The Lancet. Respiratory medicine
Published: March 11, 2025
Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial.
Journal: American journal of respiratory and critical care medicine
Published: February 12, 2025
Sputum metagenomics in bronchiectasis reveals pan-European variation: an EMBARC-BRIDGE study.
Journal: The European respiratory journal
Published: January 10, 2025
AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma.
Journal: British journal of cancer
Published: October 29, 2024
Airway IL-1β is related to disease severity and mucociliary function in bronchiectasis.
Journal: The European respiratory journal
Published: November 06, 2023
Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association".
Journal: American journal of respiratory and critical care medicine
Published: April 18, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026